Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03331718Phase 3Completed
Phase 3, randomised, open-label trial (2 arms), sponsored by University of Toyama. Primary endpoint: Incidence of a clinically relevant postoperative pancreatic fistula (ISGPS grade B/C) at 3 months. Started Oct 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03331718.